Lawsuit claims Novo Nordisk's failures to warn about the risk of gastroparesis and Ileus from Ozempic were "wanton, willful, fraudulent, reckless acts."
Side effects of Wegovy caused a West Virginia woman to develop severe gastrointestinal problems, ileus and the need for her gallbladder to be surgically removed.
Novo Nordisk allegedly knew for years about the risk that Ozempic and Rybelsus may cause ileus and other severe gastrointestinal side effects, but failed to warn doctors or patients.
Ozempic side effects resulted in the need for emergency medical care, after the diabetes drug caused her intestines to fail to contract, the lawsuit claims.
Warning labels provided for users of the GLP-1 diabetes drug downplayed the risk of gastrointestinal side effects from Trulicity, lawsuit states.
The findings add pancreatitis to the growing list of side effects of Ozempic, Wegovy and similar drugs being frequently used for weight loss, which have already been linked to reports of gastroparesis and bowel blockages
FDA label warning update comes amid growing number of lawsuits over Ozempic intestinal side effects, involving users left with stomach paralysis or gastroparesis
